Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers

Autor: Hye Rin Kang, Jun Yeun Cho, Kyung Won Lee, Sang Hoon Lee, Ho Il Yoon, Choon Taek Lee, Young Jae Cho, Jae Ho Lee, Jongsun Park, Yeon Joo Lee
Rok vydání: 2019
Předmět:
Adult
Male
0301 basic medicine
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Lung Neoplasms
Population
Adenocarcinoma of Lung
Radiation Dosage
03 medical and health sciences
0302 clinical medicine
Risk Factors
Carcinoma
Non-Small-Cell Lung

Internal medicine
medicine
Humans
education
Lung cancer
Early Detection of Cancer
Aged
Retrospective Studies
education.field_of_study
Lung
business.industry
Incidence
Smoking
Cancer
Retrospective cohort study
Middle Aged
respiratory system
Prognosis
medicine.disease
Small Cell Lung Carcinoma
respiratory tract diseases
Survival Rate
030104 developmental biology
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Carcinoma
Squamous Cell

Carcinoma
Large Cell

Adenocarcinoma
Female
National Lung Screening Trial
Tomography
X-Ray Computed

business
Lung cancer screening
Follow-Up Studies
Zdroj: Journal of Thoracic Oncology. 14:436-444
ISSN: 1556-0864
Popis: Introduction The incidence of lung cancer among never-smokers has been increasing rapidly. The U. S. National Lung Screening Trial and the NELSON trial showed that screening using low-dose computerized tomography (LDCT) effectively reduced lung cancer mortality among heavy smokers. However, its effectiveness in never-smokers has not been well investigated. This study investigated the role of LDCT in lung cancer screening among never-smokers. Methods The study was designed as a single-center, retrospective cohort study. We analyzed the data on patients who underwent LDCT screening between May 2003 and June 2016. Nodules detected by computerized tomography were classified according to the Lung Imaging Reporting and Data System criteria. The detection rate and lung cancer outcomes (type of cancer, staging of lung cancer, and mortality) according to smoking history were determined. Results Of the 28,807 enrolled patients, 12,176 were never-smokers; of these patients, 7744 (63.6%) were women and 1218 (10.0%) were found to have lung nodules. Overall, lung cancer was diagnosed in 55 never-smokers (0.45%). In contrast, lung cancer was diagnosed in 143 (0.86%) of the 16,631 ever-smokers. Of the never-smokers with lung cancer, 51 (92.7%) presented with stage I disease, and all patients had adenocarcinomas. Conclusions In the never-smoker population, LDCT screening helped to detect a significant number of lung cancers. Most of these lung cancers were detected at a very early stage. The positive results of the National Lung Screening Trial in the United States and the NELSON trial may have established the value of LDCT screening for heavy smokers, but future research should consider the value of using LDCT screening in the never-smoker population.
Databáze: OpenAIRE